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Diagnostic Ultrasound Induced Inertial Cavitation to
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Abstract
Ultrasound induced cavitation has been explored as a method of dissolving intravascular and microvascular thrombi in
acute myocardial infarction. The purpose of this study was to determine the type of cavitation required for success, and
whether longer pulse duration therapeutic impulses (sustaining the duration of cavitation) could restore both microvascular
and epicardial flow with this technique. Accordingly, in 36 hyperlipidemic atherosclerotic pigs, thrombotic occlusions were
induced in the mid-left anterior descending artery. Pigs were then randomized to either a) K dose tissue plasminogen
activator (0.5 mg/kg) alone; or same dose plasminogen activator and an intravenous microbubble infusion with either b)
guided high mechanical index short pulse (2.0 MI; 5 usec) therapeutic ultrasound impulses; or c) guided 1.0 mechanical
index long pulse (20 usec) impulses. Passive cavitation detectors indicated the high mechanical index impulses (both long
and short pulse duration) induced inertial cavitation within the microvasculature. Epicardial recanalization rates following
randomized treatments were highest in pigs treated with the long pulse duration therapeutic impulses (83% versus 59% for
short pulse, and 49% for tissue plasminogen activator alone; p,0.05). Even without epicardial recanalization, however, early
microvascular recovery occurred with both short and long pulse therapeutic impulses (p,0.005 compared to tissue
plasminogen activator alone), and wall thickening improved within the risk area only in pigs treated with ultrasound and
microbubbles. We conclude that although short pulse duration guided therapeutic impulses from a diagnostic transducer
transiently improve microvascular flow, long pulse duration therapeutic impulses produce sustained epicardial and
microvascular re-flow in acute myocardial infarction.
Citation: Xie F, Gao S, Wu J, Lof J, Radio S, et al. (2013) Diagnostic Ultrasound Induced Inertial Cavitation to Non-Invasively Restore Coronary and Microvascular
Flow in Acute Myocardial Infarction. PLoS ONE 8(7): e69780. doi:10.1371/journal.pone.0069780
Editor: Claudio Moretti, S.G.Battista Hospital, Italy
Received April 12, 2013; Accepted June 7, 2013; Published July 29, 2013
Copyright: ß 2013 Xie et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant R01 EB009050-03 from the National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD), and by the
Theodore Hubbard Foundation (Omaha, NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: TP: Lantheus Medical Imaging – Grant Support; Astellas Pharma INC. – Grant Support; Philips Research North America –Equipment
Support; NuvOx Pharma INC – Supply support; GE Healthcare – Supply support. WS: Philips Research North America – Employment. FV: Philips Research North
America – Employment. JP: Philips Medical Systems – Employment. EU: NuvOx Pharma INC – Owner. This does not alter the authors’ adherence to all the PLOS
ONE policies on sharing data and materials.
* E-mail: trporter@unmc.edu

[6,7], and the dose required to achieve this is associated with a
higher risk for both intracranial bleeding and major non-cerebral
bleeding [8,9]. Thus, any approach that could reduce fibrinolytic
dose yet rapidly restore coronary and microvascular flow would
significantly impact short and long term outcome in acute STEMI.
In vitro [10,11] and in vivo [12–15] studies have demonstrated
that ultrasound and microbubbles can dissolve intravascular
thrombi. When used as an adjunct to thrombolytic agents,
ultrasound and microbubbles have resulted in a significant
augmentation of the effectiveness of thrombolytics [13]. In
previous studies, we have shown that the application of high
mechanical index (MI) impulses from diagnostic two-dimensional
or three-dimensional ultrasound systems can dissolve thrombi with
microbubbles, even with transthoracic attenuation of the ultrasound impulses [16,17]. Microbubble cavitation has been considered as the presumptive mechanism for enhanced thrombus

Introduction
Over one million patients suffer from acute coronary syndromes
each year in the United States alone, and over 200,000 of these are
ST segment elevation myocardial infarction (STEMI) [1]. Both
short and long term prognosis in these patients are improved when
there is rapid restoration of flow in the obstructed infarct artery, if
it is also associated with restoration of microvascular flow [2–5].
Although primary coronary intervention (PCI) of the infarct
related artery is the preferred therapeutic option when it can be
performed expeditiously, the rapid restoration of epicardial flow is
still frequently accompanied by microvascular obstruction [2].
Fibrinolytic therapy has been shown to improve outcome in
STEMI, but also is frequently accompanied by microvascular
obstruction. Furthermore, the efficacy of full dose fibrinolytic
therapy in restoring epicardial flow is only slightly better than 50%
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dissolution. The rapid growth and collapse of microbubbles during
inertial cavitation results in increased shear stress along the
thrombus, and more fluid jets that penetrate the thrombus [18,19].
High speed optical observations have demonstrated that these
phenomena occur in microseconds, following which the gas nuclei
dissolve and the cavitation ceases [19]. Recent in vitro studies
have indicated that the inertial cavitation induced by a therapeutic
impulse can be sustained with a longer pulse duration. Although
most diagnostic ultrasound impulses are shorter in duration
(5 usec) to preserve spatial resolution, we hypothesized that
therapeutic impulses which sustain an inertial cavitation response
(i.e. longer pulse duration) would more likely produce greater
thrombus dissolution in a clinically relevant in vivo setting. To test
this hypothesis, we modified a conventional diagnostic imaging
system so that it produced a longer pulse duration therapeutic
ultrasound (TUS) impulse. This was then tested during an
intravenous microbubble infusion to determine a) whether it was
capable of inducing inertial cavitation within the myocardium and
b) whether it could restore epicardial and microvascular flow in an
established animal model of acute myocardial infarction.

Figure 1. Depiction of the Modified Transducer for Thrombolysis. Schematic depiction of the modified diagnostic ultrasound
transducer on the Philips S5-1 scanner. The therapeutic impulses were
sent as ensembles of four pulses of the same length, while shorter Bmode pulses of lower amplitude were interleaved for background
images of microbubble replenishment within the risk area.
doi:10.1371/journal.pone.0069780.g001

Methods
Ethics Statement
All animal studies were compliant with the standards in the
National Research Council’s Guide for the Care and Use of
Laboratory Animals and approved by the University of Nebraska
Medical Center (UNMC) Institutional Animal Care and Use
Committee (permit number: 08-069). UNMC has been accredited
by the Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC) continuously since 1966. All procedures
were performed under isoflurane anesthesia and all efforts were
made to minimize suffering by the experimental animals.

Analysis of Induced Cavitation States
In order to determine whether intra-myocardial inertial
cavitation was occurring during the two different TUS impulses
used in this study, an open chest preparation was created in two
pigs via a lateral thoracotomy. The heart was exposed and placed
in a pericardial cradle. A three centimeter thick tissue mimicking
phantom was placed over the anterior epicardium to simulate
transthoracic attenuation. A 20 MHz transducer (used as a passive
cavitation detector) was placed underneath the tissue mimicking
phantom confocal to the imaging and therapeutics transducer to
record if inertial cavitation (defined as high amplitude spikes from
the 20 MHz passive transducer) was occurring with either of the
TUS impulses. All measurements were analyzed during the same
continuous infusion of 3% MRX-801 microbubbles used for
subsequent randomized treatments. In order to confirm that the
cavitation signals were coming from the anterior myocardium (and
not the adjacent LV cavity), the oscilloscopic tracings of scattered
signals from the anterior myocardium were measured before,
during and after LAD balloon occlusion.

Microbubbles
The MRX-801 microbubbles (NuvOx Pharma, LLC, Tucson,
Arizona) used for this study are lipid encapsulated microbubbles of
a perfluoropropane gas, and have a diameter of 1.060.1 mm, with
a concentration of 1.5 to 3.061010/ml. The microbubble infusions
for the study were prepared by diluting 2 ml of the MRX-801 in
100 ml of 0.9% saline and infusing at a rate of 2.5–3.0 ml/min.

Diagnostic Ultrasound System Modification
An ultrasound system (iE33; Philips Healthcare, Andover, MA)
was modified for image-guided sonothrombolysis capability
(Figure 1). The specific modifications included: (a) a therapeutic
ultrasound (TUS) mode with a pre-defined treatment area (similar
to the box in color Doppler imaging) superimposed on the
anatomic imaging mode (B-mode); and (b) a low MI contrast-only
imaging mode for monitoring the presence (replenishment) of
microbubbles. For each TUS frame, 19 equally spaced beams
(each with an ensemble of four 1.6 MHz long pulses) were scanned
into a 54 degree angular sector area [20]. The beams were focused
at the center of the risk area. The frame rate for the TUS mode
was set to be around 50 Hz. The acoustic energy for the imaging
pulses in the background B-mode was much less that for the two
TUS settings, so the therapeutic contribution from the B-mode
was negligible. Once echo signals on the low MI contrast mode
(0.1 MI) reached a plateau intensity in the risk area, the TUS
modes with predetermined MI (2.0 and 1.0) and pulse length (5
and 20 ms respectively) were activated and TUS scanning of the
risk area proceeded from apex to base (approximately four
seconds).
PLOS ONE | www.plosone.org

Animal Preparation For Closed Chest Studies
The protocol involved 36 atherosclerotic pigs who developed
coronary atherosclerotic lesions using a previously described
protocol [17]. On day one, domestic swine were anesthetized
with isoflurane anesthesia. An 8F guide catheter was introduced
through a femoral arterial line into the left main ostium. Following
a 100 microgram injection of intracoronary nitroglycerin, baseline
angiograms were obtained and the mid left anterior descending
(LAD) sized with a digital caliper. A balloon catheter which
measured 10% larger than the vessel size was then inflated in the
LAD to create endothelial injury. Following this, the pigs were
recovered and placed on a high saturated fat-cholesterol diet for
50 days (15% Lard, 2% Cholesterol; Harlan Laboratories,
Madison, WI).

Experimental Study Protocol
At approximately 50 days following balloon injury, the pigs
were re-anesthetized. Two femoral artery and venous catheters
were placed for hemodynamic monitoring and infusions of
2
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point. Wall thickening within the central portion of the risk area
on a two dimensional short axis view (mid-papillary muscle level)
was computed from off line from end-diastolic and end-systolic
wall thickness measurements prior to treatment, and at sixty
minutes into treatment. Percent wall thickening was defined as the
difference in thickness measurements at these two time points
divided by end-diastolic wall thickness, x100% [16].
The risk area was approximated by defining the circumferential
extent of the perfusion defect during the early phase of contrast
replenishment following a high MI impulse during LAD occlusion
[21]. To determine ultimate infarct size, planimetered measurements of end-systolic defect size (hypoperfused area) were obtained
at plateau intensity at 90 minutes into treatment during low MI
imaging and a continuous infusion of microbubbles [21]. All
measurements were obtained by an experienced reviewer (JW).
Inter -observer correlations for wall thickening and perfusion
defect size at plateau intensity were also computed by comparing
the correlation of 126 wall thickness and 48 perfusion defect size
measurements obtained by second reviewer (JW).

microbubbles. A 6F pigtail catheter was inserted into the left
atrium via one arterial line to monitor left atrial pressures.
Coronary artery thrombotic occlusions were created at the same
LAD site by re-injuring the original site of balloon inflation with
an over-sized balloon. Specific angiographic markers were used
(e.g. location in distance from a diagonal branch) to ensure that
injury was at the same location as day one. After re-injury, the
balloon was withdrawn proximal to the injury site and partially
inflated to create vessel stasis. Following this, small 0.1–0.2
milliliter aliquots of thrombosed venous blood (obtained from the
same animal) were introduced through the partially inflated
balloon catheter to create a hypercoagulable state. Once
angiographic LAD occlusion was documented, it had to persist
for at least 20 minutes before randomization. If spontaneous
recanalization occurred, additional 0.1–0.2 milliliter aliquots of
thrombus were again administered through the balloon catheter
until persistent occlusion was observed.
The percent oxygen mixture was kept at 24% during treatment
periods in all pigs. Low-dose intravenous dobutamine (1 to 3 ug/
kg per minute) was used, if necessary, to maintain systolic arterial
pressure .90 mm Hg during the study protocol. Lidocaine
boluses (40 mg IV followed by 20 mg IV boluses 63) and a
continuous lidocaine infusion (2 to 4 mg/min IV) were used in all
animals to control arrhythmias. Direct current cardioversions (300
Joules) were used, as necessary, to treat sustained ventricular
tachycardia or ventricular fibrillation.
Just prior to randomized treatment, pigs had baseline measurements of heart rate, oxygen saturation, arterial blood pressure, and
left atrial pressure. Wall thickening and perfusion defect size (see
below) were determined during a 3% intravenous microbubble
infusion (MRX 801; NuVox Pharma; Tuscon, Arizona) using low
MI imaging (0.2 MI; Power Modulation; Philips S5-1). Maximum
ST segment elevation was measured with a 12 lead EKG.
Subsequently, all pigs received 650 milligrams of aspirin per a
nasogastric tube, followed by an intravenous heparin bolus
(80 mg/kg), and a low dose of fibrinolytic agent (0.5 mg/kg tissue
plasminogen activator administered over 30 minutes). The pigs
were randomized into three groups: no additional treatment
(n = 12; referred to as Group I); a continuous intravenous infusion
of MRX-801 with intermittent 2.0 MI short duration TUS
impulses (1.6 MHz; 5 usec pulse duration, subsequently referred
to as Group II, N = 12) and intermittent 1.0 MI longer duration
TUS impulses (1.6 MHz; 20 usec pulse duration; Group III,
N = 12). The lower MI was used for the longer TUS pulse
duration to match the energy outputs in Groups II and III. TUS
impulses were administered for five seconds while manually
scanning the anterior myocardium from apex to base. In between
TUS pulses, low MI imaging (Power Modulation) was used with
end-systolic triggering to detect for microbubbles within the risk
area, which was defined as the region exhibiting a contrast defect
during the replenishment phase of contrast following therapeutic
impulses (Figure 2). All treatment durations were 30 minutes.
Venous samples for activated clotting times (ACTs) were obtained
before initiation of treatment and at approximately 30 minutes
into randomized treatments.

Post Mortem Measurements
After the 90 minute angiograms, the pigs were sacrificed. The
LAD coronary artery was dissected and analyzed with Hematoxylin/Eosin staining for presence of intra-coronary thrombus, focal
dissection, and evidence of underlying atherosclerosis, as determined by the presence of fatty streaks and intimal hyperplasia.
Percent vascular obstruction by the underlying plaque was visually
graded as 0–25%, 25–50%, and 50–75% using established criteria
[22]. The LAD proximal to the balloon injury site was examined
for evidence of endothelial damage or hemorrhage that may have
been as a result of the high MI impulses. All analyses here were
done by an experienced cytopathologist (SJR) blinded to treatment
assignment.
Prior to sacrifice in nine pigs, Evan’s Blue was injected into the
right and left coronary arteries during the mid left anterior
descending balloon occlusion (at the site of the original injury) to
correlate risk area, determined by this stain, with myocardial
contrast echocardiographic defect size during the early replenishment phase of contrast immediately following high MI impulses.

Statistical Analysis
Hemodynamic and echocardiographic changes within groups
before and after treatment, as well as activated clotting time
measurements before and after treatment, were compared using
paired t testing. Comparisons of recanalization rates between the
three treatment groups were compared using contingency tables.
Comparisons of wall thickening changes, ST segment changes,
and changes in plateau intensity perfusion defect size between
groups were perfomed using analysis of variance. The relationship
between perfusion defect size during the early replenishment phase
contrast following high MI impulses and actual risk area measured
with intracoronary Evan’s Blue injections during LAD occlusion
were determined with a Pearson correlation coefficient. In all
cases, p values ,0.05 were considered significant.

Results

Outcome Measurements

Cavitational Analysis of Therapeutic Impulses

In all pigs, epicardial recanalization was assessed by angiography using left main coronary artery injections of five milliliters of
iodinated contrast at 30, 60, and 90 minutes following initiation of
treatment protocols. Twelve lead EKG’s were obtained at baseline
prior to treatment, and at 30, 60, and 90 minutes into each
randomized treatment. Maximal ST segment elevation, and % ST
segment resolution from maximum, were compared at each time
PLOS ONE | www.plosone.org

Cavitation signals received by the passive cavitation detector in
the open chest pigs during application of the two different applied
TUS impulses are shown in Figure 3. Note that inertial cavitation
(the signal spikes measured on the oscilloscope) was present during
the application of both the short and long TUS impulses used in
the study. There were no differences in the amplitude of
3

July 2013 | Volume 8 | Issue 7 | e69780

Ultrasonic Angioplasty in Acute MI

Figure 2. Myocardial Perfusion Images. Myocardial perfusion images from the low MI contrast imaging that were used to guide the application
of the therapeutic ultrasound (TUS) impulses. Note that after the TUS impulses, there was no myocardial contrast present in the left circumflex or left
anterior descending perfusion beds (Second panel from the left). During low MI triggered imaging, early replenishment delineated the risk area
(arrows; third panel from the left). A plateau intensity was reached (right panel), which was when the TUS impulses were re-applied.
doi:10.1371/journal.pone.0069780.g002

cavitational activity (which indicates the magnitude of growth and
collapse of the microbubbles) between the 2.0 MI short pulse
duration impulses and the 1.0 MI longer pulse duration impulses.
However, since the 20 usec pulse lasts four times longer than the
5 usec pulse, the aggregate cavitational activity for the 20 usec
pulse was nearly four times longer (0.73 volt-seconds versus 0.22
volt-seconds). These inertial cavitation signals were confirmed to
be coming from the anterior myocardium, as they almost
completely disappeared during LAD occlusion, and reappeared
when applied following reperfusion of the LAD (Figure 4).

Angiographic, Electrocardiographic, and Wall Thickening
Measurements
The pigs in group III had an 83% angiographic recanalization
rate at 30, 60 and 90 minutes (compared to 42%, 42% and 45%
for Group I pigs or TPA alone, respectively; p,0.05). Recanalization rates for group II (short pulse TUS impulses) were 58% at
these same time periods. Figure 3 is an example of a coronary
angiogram of a recanalized left anterior descending artery after 30
minutes of treatment with the long duration 1.0 MI TUS impulse,
as well as the improvement in myocardial perfusion within the risk
area after treatment. In both Group II and III pigs, there was
more rapid replenishment of microbubbles within the risk area
following high MI impulses, as treatment time progressed
(Figure 3).
Both short (Group II) and long (Group III) pulse TUS treated
pigs exhibited improved microvascular flow by EKG. ST segment
change improved 60% at 30 minutes into treatment in group III,
compared to 48% in group II and 10% in group I (P,0.05 for
both Group III and Group II vs. Group I). ST segment resolution
.50% at 60 minutes into treatment occurred in 10 of 12 pigs
(83%) in Group III, eight of 12 pigs (67%) in group II, and four of
12 pigs (33%) in Group I (P = 0.006). Wall thickening within the
risk area at 60 minutes was significantly improved in Group III
and Group II pigs compared to Group I.

Hemodynamic Comparisons
Table 1 summarizes the hemodynamic, heart rate, and oxygen
saturation measurements following coronary occlusion just prior to
treatment, and at sixty minutes following initiation of treatment.
There were no differences between groups in any of these
parameters before or after randomized treatments, except
activated clotting times due to heparin. The amount of thrombus
required to occlude the LAD was 0.560.1 ml in Group I,
0.560.2 ml in Group II, and 0.560.2 ml in Group III. No
ventricular arrhythmias were noted during application of either of
the TUS impulses at any stage of the 30 minute treatment period.

Figure 3. Intra-myocardial Passive Cavitation Detector Recordings During Therapeutic Impulses. Passive cavitation detector recordings
from the anterior myocardium during a continuous infusion of microbubbles and application of the long pulse duration 1.0 MI (left panel) and short
pulse 2.0 MI (right panel) therapeutic impulses. The black dots above the baseline signal represent inertial cavitational activity, which disappeared
when the left anterior descending was occluded (The ‘‘TUS On’’ following balloon inflation), confirming that recorded activity was intra-myocardial.
Note that the amplitude of the voltage, and number of recorded events produced by the cavitational spikes were similar for the two different
therapeutic impulses. However, since the 20 usec pulse lasts four times longer than the 5 usec pulse, the aggregate cavitational activity for the
20 usec pulse is nearly four times longer (0.73 volt-seconds versus 0.22 volt-seconds).
doi:10.1371/journal.pone.0069780.g003
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Figure 4. Microvascular and Angiographic Recanalization with Echo Guided Long Pulse Duration Therapeutic Impulses. The
angiographic results in one of Group III pigs treated with guided long pulse duration TUS impulses. The short axis echocardiographic images
delineate myocardial contrast enhancement at incremental cardiac cycles following the therapeutic impulse. The cycle number represents the
number of cardiac cycles that have occurred following cessation of the TUS impulses. Although there was minimal capillary replenishment noted at
0–5 minutes into therapy, at 20–25 minutes there was more rapid restoration of contrast enhancement within the LAD risk area. Note angiographic
recanalization was observed, (right lower panel), as well as improved microvascular perfusion (as indicated by the rapid replenishment of
microbubbles into the risk area) at 20–25 minutes into therapy.
doi:10.1371/journal.pone.0069780.g004

Plateau myocardial contrast defect size improved only in
Groups II and III pigs (Table 2). Contrast defect size improved
even in the pigs that did not exhibit epicardial recanalization
(p = 0.003), but not in the pigs treated with TPA alone.
Interobserver correlation in measurements of wall thickening
and perfusion defect size were r = 0.96 (n = 126 comparisons) and
r = 0.91 (n = 48 comparisons), respectively. In the nine separate
pigs used to validate risk area measurements, there was a close
correlation between risk area calculated by contrast perfusion
defect size during early replenishment following high MI impulses
measured with MCE in the initial phases of treatment, and that
seen with Evans Blue staining during LAD occlusion (r = 0.82,
p,0.005).

Post Mortem Coronary Artery Measurements
Post mortem pathologic analysis of the LAD was not possible in
two pigs. Evidence of early atherosclerotic lesions within the
balloon injured portion of the LAD was evident in 31 of the
remaining 34 pigs (91%). In 25 of these pigs (74%), the obstruction
created by plaque was ,25%, while in six it was either 25–50%
(n = 3) or 50–75% (n = 3) in severity. In three pigs, there was no
evidence of plaque formation at the site of injury. There was
evidence of focal intimal dissection (as a result of the balloon
injury) in 19 pigs (56%). No differences were observed between
treatment groups in the presence or absence of any of these
parameters.

Discussion
This prospective randomized pre-clinical study has demonstrated that a modified diagnostic ultrasound system can be utilized
with intravenous microbubbles and a low dose of TPA to rapidly
restore epicardial and microvascular flow in acute STEMI. The
TUS impulses that improved both epicardial and microvascular

Table 1. Hemodynamic Characteristics.

Group I

Group II

Group III

Before After

Before After

Heart rate
(beat/minute)

96614

95613

101611 93615

105616

Systolic arterial
pressure
(mmHg)

107612 10569

10569

99611

99611

iastolic arterial
pressure
(mmHg)

73610

SpO2 (%)

10060

10061

10060

10060

10060

10060

Left atrial
pressures
(mmHg)

764

663

861

764

864

863

ACT (s)

114614 187619* 112612 181625* 115613 187620*

100611

Before After

10567

Table 2. Wall thickening and perfusion defect size (at plateau
intensity) before and following treatment.

Group I
69615

76612

67612

72611

65614

Group III

Baseline WT

865%

967%

1168%

60 minutes WT

1169%

2568%

19612%

WT % Improvement

365%

15612%*

8610%*

Baseline PD Size

1.7460.69 cm2

1.6760.59 cm2

1.7160.65 cm2

60 minutes PD Size

1.4860.35 cm2

1.1960.62 cm2 * 0.8460.51 cm2 *

*p,0.05 compared to Group I. Group I = 1/2 dose TPA alone; Group II = 1/2
dose TPA with guided short pulse duration TUS impulses; Group III = 1/2 dose
TPA with guided long pulse duration TUS impulses.WT = wall thickening;
PD = perfusion defect.
doi:10.1371/journal.pone.0069780.t002

*,0.001 compared to before treatment.
doi:10.1371/journal.pone.0069780.t001

PLOS ONE | www.plosone.org
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flow were of longer duration than those used for diagnostic
imaging, but still at an MI that would still be considered within
Food and Drug Administration limits. We also documented that
this longer pulse duration TUS impulse induced inertial cavitation
within the microvasculature, and, unlike TUS impulses of shorter
duration, was able to recanalize the epicardial vessels as well as the
microvasculature. The key mechanistic difference between the two
TUS impulses tested was the ability of the long pulse duration to
sustain the cavitation effect for longer microsecond intervals.
Thrombotic coronary occlusions produce downstream microthrombi, which are believed to play a significant role in the noreflow phenomena [23]. This microvascular obstruction prevents
restoration of function within the risk area, and can persist even
after epicardial recanalization. Previous studies have demonstrated
improved microvascular perfusion to the risk area with short pulse
transthoracic ultrasound-induced microbubble cavitation, even
without early epicardial recanalization [16,17]. One mechanism
for this microvascular improvement, in the absence restored
anterograde blood flow, appears to be ultrasound induced
endothelial nitric oxide release, resulting in vasodilation and
improved flow from collateral vessels [24,25]. In our study, the
TUS impulses did improve microvascular function acutely even
without epicardial recanalization, as evidenced by ST segment
resolution, reductions in perfusion defect size, and early improvements in wall thickening within the risk area. These findings are
consistent with studies examining improvements of tissue perfusion
in the presence of persistent upstream occlusion. However, in the
absence of epicardial recanalization, these improvements were
present primarily when the ultrasound was applied, and reversed
when ultrasound was withdrawn. Therefore, it would appear
critical that any therapeutic technique in this setting should also
restore anterograde epicardial blood flow. In this context, the
guided long pulse TUS impulses would have the advantage over
current therapies, in that they can both maintain microvascular
function and rapidly restore epicardial flow.
The in vivo inertial cavitation measurements demonstrated that
longer pulse duration therapeutic impulses at a lower MI may
have beneficial mechanistic effects over high MI shorter duration
impulses, because they prolong the duration of induced cavitation.
This may have several clinical advantages as well. Since the
inertial cavitation with the longer pulse was achieved with a lower
MI, it may be less likely to cause any unwanted bioeffects, such as
arrhythmias or myocyte damage [26]. Secondly, the sustained
cavitation induced by the longer pulse duration could potentially
result in more exposure of plasmin binding sites for the coadministered low dose plasminogen activator [27]. Thirdly,
sustaining inertial cavitation with the longer pulse duration would
result in more fluid jets from cavitating microbubbles, and
improve the likelihood of more rapidly mechanically dissolving
the thrombus in both the epicardial vessel and the microvasculature.
The augmentation of thrombolysis with ultrasound and
microbubbles observed in this study is similar to what has been
observed in animal models of acute thrombo-embolic stroke,
where transtemporal ultrasound and microbubbles alone have
reduced stroke size similar to what full dose TPA (0.9 mg/kg)
achieved [28]. In these animal studies, a longer 1 Megahertz pulse
(20% duty cycle) at a lower mechanical index was utilized to
cavitate microbubbles. By reducing or even eliminating the need
for fibrinolytic therapy, ultrasound and microbubbles could
expand the number of patients in each of these clinical settings
who are eligible for therapy, especially those who are at increased
risk for bleeding (e.g. elderly patients or patients with prior stroke).
In the setting of acute stroke in animal models, the utilization of
PLOS ONE | www.plosone.org

ultrasound and microbubbles alone has reduced infarct size, and
been shown to reduce the frequency of intracranial hemorrhage
when compared to fibrinolytic therapy [29].

Limitations of the Study
Although the majority of pigs in this study developed some
degree of early atherosclerotic plaque within the balloon injured
area, the severity of underlying plaque was less than 50%. It is
unclear how effective the long pulse duration TUS impulses would
be when more advanced forms of atherosclerosis and calcification
are present. Furthermore, the thrombotic occlusion was fresh and
less than two hours old in the model tested, and thus it is unknown
what results would be expected if the time interval between
occlusion and treatment was longer than this.
We only tested one longer pulse duration TUS impulse, in order
to stay close to Food and Drug Administration limits. It is possible
that even longer pulse durations than those used in this study may
be more effective for thrombolysis. However, longer pulse
durations may increase the risk for heating in low flow areas,
which may be counterproductive in this setting [30,31]. This may
require alterations in transducer design, such as capacitive
micromachined ultrasound transducers, which do not have as
much self-heating problems as piezoelectric transducers [32].
Finally, we did not test what effect stable cavitation alone may
have in this setting, since inertial cavitation was induced by both of
the TUS impulses. Although stable cavitation is effective in
improving the effectiveness of fibrinolytic therapy in vitro, in vivo
studies have demonstrated that the inertial cavitation threshold
must be reached before effective intravascular thrombolysis occurs
[33].

Clinical Implications
The model chosen for this study emulates the setting in which
most myocardial infarctions occur clinically. Usually thrombotic
occlusions occur from ruptured plaques that were previously nonobstructive [34,35], resulting in coronary occlusions that are
composed of predominately thrombus. Underlying plaque was
present in the majority of pigs in this study, but was ,25%
diameter in over 70% of pigs. In this setting, the 83% epicardial
recanalization rate achieved with the long pulse duration TUS
impulses is comparable to that seen with interventional percutaneous therapies. Moreover, since echocardiography is more
portable and readily available to the patient than interventional
laboratories, this therapy could reach a higher number of patients
more rapidly, resulting in greater degrees of myocardial salvage in
acute STEMI.
The long pulse duration TUS impulses used in this study were
administered from a modified commercially available diagnostic
transducer, and the intravenous microbubbles were very similar to
the commercially available microbubble Definity (Lantheus
Medical). The TUS impulses also did not induce arrhythmias
when they were applied, indicating the TUS impulses were not
causing unwanted bioeffects within the coronary artery. Furthermore, the TUS impulses, even if they did not restore epicardial
flow, did have a temporary effect of improving microvascular flow,
and thus may be able to salvage myocardium until epicardial flow
is restored by interventional techniques. Therefore, this approach
may be effective, with or without low dose TPA, in a clinical
setting where emergent percutaneous therapy is not feasible, or
where there may be increased bleeding risk associated with higher
doses of TPA. With guided long pulse duration TUS impulses, one
could non-invasively achieve epicardial recanalization rates that
approach that seen with interventional therapies, and, more
6
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importantly, overcome the problem of persistent microvascular
obstruction that complicates current state of the art therapies.
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